Three Motley Fool contributors believe they've identified dividend stocks to buy in September that fall into the latter ...

The global Wearable Injectors Market, valued at US$10.2 billion in 2024, stood at US$11.33 billion in 2025 and is projected ...

ABBV's expanding neuroscience portfolio, led by Botox, Vraylar and new launches like Vyalev, continues to fuel top-line ...

Parkinson's drugs market with our report, analyzing trends, revenue projections, and CAGRs from 2024 to 2030. Segmented by ...

A licensing deal worth at least $200 million will give Novartis access to a preclinical RNA medicine designed to combat ...

​近日，艾伯维宣布将以最高12亿美元的价格收购Gilgamesh ...

A shocking incident of violence unfolded in central Athens on Thursday night (August 7, 2025), as two French tourists reported being attacked and robbed by a taxi driver in the Omonoia area. The ...

"We are honored to welcome Josephine and Joe to our Board," said Bob Whitehead, Co-Founder and Executive Chairman of Continuity Biosciences. "Josephine's regulatory acumen and clear-eyed judgment are ...

We also delivered strong double-digit growth from neuroscience, driven by Vraylar, Vyalev and our leading migraine portfolio. Based on our momentum through the first half of the year, we are raising ...